Mahacef 200 Tablet contains Cefixime 200 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death, thereby exhibiting bactericidal activity. It is commonly prescribed for the treatment of infections caused by susceptible strains of gram-positive and gram-negative bacteria, including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, otitis media, pharyngitis, and gonorrhea. Mahacef 200 is indicated for adults and children over a specified age and weight, with dosage tailored according to the severity and type of infection. The drug is well absorbed orally, achieving therapeutic concentrations in various body tissues and fluids. It is generally well tolerated; however, adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions in sensitive individuals. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Renal function should be monitored in patients with impairment, as dose adjustment may be necessary. Mahacef 200 should be used under medical supervision with adherence to the prescribed dosage and duration to prevent resistance development and ensure optimal clinical outcomes.